Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach

Rapid push: new opportunities in subcutaneous immunoglobulin replacement therapy

Central European Journal of Immunology ◽

10.5114/ceji.2013.37760 ◽

2013 ◽

Vol 3 ◽

pp. 388-392 ◽

Cited By ~ 1

Author(s):

Małgorzata Pac ◽

Ewa Bernatowska

Keyword(s):

Replacement Therapy ◽

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Therapeutics and Clinical Risk Management ◽

10.2147/tcrm.s4353 ◽

2009 ◽

pp. 1 ◽

Cited By ~ 1

Author(s):

Hans Ochs

Keyword(s):

Replacement Therapy ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Disease ◽

Immunoglobulin Replacement ◽

Immunodeficiency Disease

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.2012.04594.x ◽

2012 ◽

Vol 169 (2) ◽

pp. 172-181 ◽

Cited By ~ 74

Author(s):

J. S. Orange ◽

B. H. Belohradsky ◽

M. Berger ◽

M. Borte ◽

J. Hagan ◽

...

Keyword(s):

Replacement Therapy ◽

Clinical Outcomes ◽

Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century

Annals of Allergy Asthma & Immunology ◽

10.1016/s1081-1206(10)60197-4 ◽

2008 ◽

Vol 101 (2) ◽

pp. 114-121 ◽

Cited By ~ 39

Author(s):

Meredith L. Moore ◽

James M. Quinn

Keyword(s):

Replacement Therapy ◽

21St Century ◽

Antibody Deficiency ◽

Primary Antibody ◽

Primary Antibody Deficiency ◽

Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age

Journal of Clinical Immunology ◽

10.1007/s10875-015-0190-0 ◽

2015 ◽

Vol 35 (6) ◽

pp. 558-565 ◽

Cited By ~ 6

Author(s):

Niraj C. Patel ◽

Joel L. Gallagher ◽

Hans D. Ochs ◽

Thomas Prescott Atkinson ◽

Justin Wahlstrom ◽

...

Keyword(s):

Replacement Therapy ◽

Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies

Medical Journal of the Islamic Republic of Iran ◽

10.14196/mjiri.31.94 ◽

2017 ◽

Vol 31 (1) ◽

pp. 548-554 ◽

Cited By ~ 2

Author(s):

Hosein Shabaninejad ◽

Asra Asgharzadeh ◽

Aziz Rezapour ◽

Nima Rezaei

Keyword(s):

Cost Effectiveness ◽

Replacement Therapy ◽

Cost Effectiveness Analysis ◽

Primary Immunodeficiencies ◽

Effectiveness Analysis ◽

Immunoglobulin Replacement ◽

Iranian Patients

The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2020.04.006 ◽

2020 ◽

Vol 20 (9) ◽

pp. e590-e596

Author(s):

S. Shahzad Mustafa ◽

Saad Jamshed ◽

Karthik Vadamalai ◽

Allison Ramsey

Keyword(s):

B Cell ◽

Replacement Therapy ◽

Hodgkin Lymphoma ◽

Immune Dysfunction ◽

Humoral Immune ◽

Non Hodgkin Lymphoma ◽